CLINDAMYCIN PALMITATE HYDROCHLORIDE

CLINDAMYCIN PALMITATE HYDROCHLORIDE was reported 228 times

CLINDAMYCIN PALMITATE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS 1 0.1667
1 MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS 1 0.0556
2 NEONATAL CANDIDA INFECTION 1 0.0233
3 NEURONE-SPECIFIC ENOLASE INCREASED 1 0.0233
4 EYE INFARCTION 1 0.0100
5 CONGENITAL ANOMALY IN OFFSPRING 1 0.0076
6 PRODUCT WITH QUALITY ISSUE ADMINISTERED 3 0.0067
7 MICROSPORIDIA INFECTION 2 0.0057
8 TOXIC SHOCK SYNDROME STREPTOCOCCAL 1 0.0052
9 FACTOR V INHIBITION 1 0.0052
10 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
11 DYSBACTERIOSIS 1 0.0047
12 AUTOIMMUNE NEUTROPENIA 1 0.0035
13 SPUTUM PURULENT 2 0.0030
14 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 2 0.0024
15 FEEDING INTOLERANCE 1 0.0022
16 BURNING MOUTH SYNDROME 1 0.0018
17 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
18 TOXIC SHOCK SYNDROME 1 0.0016
19 SJS-TEN OVERLAP 1 0.0014
20 PELVIC FLUID COLLECTION 1 0.0014
21 GLOMERULONEPHRITIS MINIMAL LESION 1 0.0014
22 PRODUCT ODOUR ABNORMAL 14 0.0013
23 KOUNIS SYNDROME 3 0.0013
24 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
25 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
26 SKIN TEST POSITIVE 1 0.0011
27 PYURIA 1 0.0010
28 RETINAL TOXICITY 1 0.0010
29 CLOSTRIDIUM TEST POSITIVE 2 0.0009
30 VANISHING BILE DUCT SYNDROME 1 0.0009
31 KLEBSIELLA SEPSIS 1 0.0009
32 CATHETER RELATED COMPLICATION 1 0.0009
33 PRODUCT TASTE ABNORMAL 12 0.0009
34 CHRONIC RESPIRATORY FAILURE 1 0.0008
35 XEROSIS 1 0.0008
36 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
37 RETINAL DEGENERATION 1 0.0008
38 HYPERSENSITIVITY VASCULITIS 2 0.0008
39 MACULAR HOLE 1 0.0007
40 PNEUMATOSIS INTESTINALIS 2 0.0007
41 COMA SCALE ABNORMAL 2 0.0007
42 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
43 MEGACOLON 1 0.0006
44 INAPPROPRIATE AFFECT 1 0.0006
45 ENTEROCOCCAL INFECTION 3 0.0006
46 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
47 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
48 INCORRECT STORAGE OF DRUG 1 0.0006
49 ORGAN FAILURE 2 0.0005
50 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
51 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
52 CHOLESTATIC LIVER INJURY 1 0.0004
53 PSEUDOMEMBRANOUS COLITIS 1 0.0004
54 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
55 IMMUNE THROMBOCYTOPENIA 2 0.0004
56 METHAEMOGLOBINAEMIA 1 0.0004
57 VOLVULUS 1 0.0004
58 KLEBSIELLA INFECTION 2 0.0004
59 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
60 GASTROINTESTINAL INJURY 1 0.0004
61 GAMBLING DISORDER 1 0.0004
62 SERUM SICKNESS 1 0.0004
63 OESOPHAGEAL STENOSIS 1 0.0004
64 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
65 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
66 EXPOSURE TO TOXIC AGENT 1 0.0003
67 POOR QUALITY DRUG ADMINISTERED 2 0.0003
68 HYPOVENTILATION 1 0.0003
69 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
70 WOUND COMPLICATION 1 0.0003
71 FIBRIN D DIMER INCREASED 1 0.0003
72 PRODUCT CONTAMINATION 1 0.0003
73 FOOD INTOLERANCE 1 0.0003
74 THROMBOCYTOSIS 1 0.0003
75 OESOPHAGEAL ULCER 1 0.0003
76 POST PROCEDURAL HAEMORRHAGE 3 0.0003
77 ANAPHYLACTOID REACTION 1 0.0002
78 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
79 PSEUDOMONAS INFECTION 2 0.0002
80 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
81 LOCALISED OEDEMA 1 0.0002
82 ROSACEA 1 0.0002
83 STAPHYLOCOCCAL SEPSIS 1 0.0002
84 PRODUCT ADMINISTRATION ERROR 4 0.0002
85 DYSPHORIA 1 0.0002
86 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
87 TOXIC ENCEPHALOPATHY 1 0.0002
88 PRODUCT COLOUR ISSUE 1 0.0002
89 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
90 CHEILITIS 1 0.0002
91 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
92 RASH MACULO-PAPULAR 4 0.0002
93 NEPHROPATHY TOXIC 2 0.0002
94 NEUTROPHILIA 1 0.0002
95 EOSINOPHILIA 3 0.0002
96 SEPTIC SHOCK 7 0.0002
97 DRUG RESISTANCE 4 0.0002
98 HUNGER 2 0.0001
99 PAROSMIA 1 0.0001
100 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
101 ATRIOVENTRICULAR BLOCK 1 0.0001
102 TORSADE DE POINTES 1 0.0001
103 PRODUCT USE COMPLAINT 2 0.0001
104 URINE OUTPUT DECREASED 1 0.0001
105 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
106 DRUG ERUPTION 2 0.0001
107 RESPIRATORY RATE INCREASED 1 0.0001
108 HEAVY MENSTRUAL BLEEDING 1 0.0001
109 IRON DEFICIENCY ANAEMIA 1 0.0001
110 ARTERIOSCLEROSIS 1 0.0001
111 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
112 RENAL TUBULAR NECROSIS 1 0.0001
113 KNEE OPERATION 1 0.0001
114 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
115 PRODUCT PHYSICAL ISSUE 2 0.0001
116 DRUG-INDUCED LIVER INJURY 3 0.0001
117 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
118 INCONTINENCE 1 0.0001
119 OESOPHAGITIS 1 0.0001
120 GASTROINTESTINAL PAIN 1 0.0001
121 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
122 INTESTINAL PERFORATION 1 0.0001
123 MYOCARDITIS 1 0.0001
124 GASTRIC HAEMORRHAGE 1 0.0001
125 ELECTROLYTE IMBALANCE 1 0.0001
126 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
127 PRODUCT STORAGE ERROR 7 0.0001
128 HEPATITIS 2 0.0001
129 NODULE 1 0.0001
130 JAUNDICE 2 0.0001
131 GINGIVAL BLEEDING 1 0.0001
132 BLOOD TEST ABNORMAL 1 0.0001
133 ANGIOEDEMA 3 0.0001
134 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
135 OSTEOPENIA 1 0.0001
136 DELUSION 1 0.0001
137 ACUTE MYELOID LEUKAEMIA 1 0.0001
138 HALLUCINATION, AUDITORY 1 0.0001
139 MULTI-ORGAN FAILURE 1 0.0001
140 ISCHAEMIC STROKE 1 0.0001
141 LEUKOCYTOSIS 1 0.0001
142 OSTEOMYELITIS 1 0.0001
143 ANAPHYLACTIC REACTION 3 0.0001
144 CONJUNCTIVITIS 1 0.0001
145 AGRANULOCYTOSIS 1 0.0001
146 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
147 INTESTINAL OBSTRUCTION 2 0.0001
148 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
149 PYREXIA 17 0.0000
150 TREATMENT FAILURE 4 0.0000
151 HAEMORRHAGE 5 0.0000
152 DERMATITIS 1 0.0000
153 IRRITABLE BOWEL SYNDROME 1 0.0000
154 PRODUCT PRESCRIBING ISSUE 1 0.0000
155 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
156 STEVENS-JOHNSON SYNDROME 1 0.0000
157 GLOSSODYNIA 1 0.0000
158 ORAL PAIN 1 0.0000
159 PRODUCT PRESCRIBING ERROR 1 0.0000
160 RASH ERYTHEMATOUS 2 0.0000
161 LIVER INJURY 1 0.0000
162 ENCEPHALOPATHY 1 0.0000
163 OSTEONECROSIS OF JAW 1 0.0000
164 DYSGEUSIA 3 0.0000
165 AGEUSIA 1 0.0000
166 LEUKOPENIA 2 0.0000
167 ANAPHYLACTIC SHOCK 1 0.0000
168 INFLAMMATION 2 0.0000
169 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
170 RESPIRATORY TRACT INFECTION 1 0.0000
171 BRADYCARDIA 2 0.0000
172 RESPIRATORY DISTRESS 1 0.0000
173 ABNORMAL DREAMS 1 0.0000
174 RED BLOOD CELL COUNT DECREASED 1 0.0000
175 HYPERSOMNIA 1 0.0000
176 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
177 ASCITES 1 0.0000
178 DISEASE PROGRESSION 4 0.0000
179 BLOOD POTASSIUM DECREASED 1 0.0000
180 HEPATIC FAILURE 1 0.0000
181 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
182 HYPOTHYROIDISM 1 0.0000
183 EYE DISORDER 1 0.0000
184 LIP SWELLING 1 0.0000
185 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
186 CONDITION AGGRAVATED 9 0.0000
187 HAEMATURIA 1 0.0000
188 HYPOXIA 1 0.0000
189 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
190 VOMITING 13 0.0000
191 CRYING 1 0.0000
192 HYPERGLYCAEMIA 1 0.0000
193 RESPIRATORY FAILURE 2 0.0000
194 RESTLESSNESS 1 0.0000
195 COLITIS 1 0.0000
196 ACUTE KIDNEY INJURY 4 0.0000
197 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
198 DYSKINESIA 1 0.0000
199 BLINDNESS 1 0.0000
200 NEUTROPHIL COUNT DECREASED 1 0.0000
201 DRUG INEFFECTIVE 32 0.0000
202 URTICARIA 4 0.0000
203 SKIN EXFOLIATION 2 0.0000
204 RENAL FAILURE ACUTE 1 0.0000
205 RECTAL HAEMORRHAGE 1 0.0000
206 DEVICE DISLOCATION 1 0.0000
207 RASH 10 0.0000
208 TACHYCARDIA 2 0.0000
209 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
210 PULMONARY OEDEMA 1 0.0000
211 GASTROINTESTINAL DISORDER 2 0.0000
212 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
213 THERAPY NON-RESPONDER 1 0.0000
214 SKIN DISCOLOURATION 1 0.0000
215 HYPERSENSITIVITY 4 0.0000
216 THERAPY CESSATION 1 0.0000
217 PANCREATITIS 1 0.0000
218 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
219 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
220 HAEMATOCHEZIA 1 0.0000
221 SEPSIS 2 0.0000
222 ABDOMINAL DISCOMFORT 3 0.0000
223 BLISTER 1 0.0000
224 ASTHMA 2 0.0000
225 FLATULENCE 1 0.0000
226 HERPES ZOSTER 1 0.0000
227 ABDOMINAL PAIN 4 0.0000
228 SURGERY 1 0.0000
229 DIARRHOEA 11 0.0000
230 NASAL CONGESTION 1 0.0000
231 CHEST PAIN 3 0.0000
232 EXPOSURE DURING PREGNANCY 1 0.0000
233 PRURITUS 6 0.0000
234 LOSS OF CONSCIOUSNESS 2 0.0000
235 RHINORRHOEA 1 0.0000
236 DEEP VEIN THROMBOSIS 1 0.0000
237 SWELLING FACE 1 0.0000
238 BLOOD CREATININE INCREASED 1 0.0000
239 FEBRILE NEUTROPENIA 1 0.0000
240 RENAL FAILURE 2 0.0000
241 ABDOMINAL PAIN UPPER 3 0.0000
242 THERAPY INTERRUPTED 1 0.0000
243 AGITATION 1 0.0000
244 PRODUCT DOSE OMISSION ISSUE 4 0.0000
245 EPISTAXIS 1 0.0000
246 DIABETES MELLITUS 1 0.0000
247 NAUSEA 10 0.0000
248 DRUG INTERACTION 2 0.0000
249 FEELING ABNORMAL 3 0.0000
250 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
251 DRY MOUTH 1 0.0000
252 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
253 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
254 MYALGIA 2 0.0000
255 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
256 INSOMNIA 3 0.0000
257 BLOOD GLUCOSE INCREASED 2 0.0000
258 DYSPNOEA 6 0.0000
259 DYSPHAGIA 1 0.0000
260 ANAEMIA 2 0.0000
261 DRUG INTOLERANCE 1 0.0000
262 SYNCOPE 1 0.0000
263 HYPOTENSION 2 0.0000
264 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
265 ILLNESS 1 0.0000
266 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
267 ABDOMINAL DISTENSION 1 0.0000
268 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
269 CONSTIPATION 2 0.0000
270 THROMBOCYTOPENIA 1 0.0000
271 DEPRESSION 2 0.0000
272 SEIZURE 1 0.0000
273 CHILLS 1 0.0000
274 OEDEMA PERIPHERAL 1 0.0000
275 HYPERHIDROSIS 1 0.0000
276 DEHYDRATION 1 0.0000
277 PRODUCT QUALITY ISSUE 1 0.0000
278 NEUTROPENIA 1 0.0000
279 COUGH 2 0.0000
280 ANXIETY 2 0.0000
281 INFECTION 1 0.0000
282 OFF LABEL USE 6 0.0000
283 MALAISE 3 0.0000
284 BLOOD PRESSURE INCREASED 1 0.0000
285 URINARY TRACT INFECTION 1 0.0000
286 COVID-19 1 0.0000
287 SOMNOLENCE 1 0.0000
288 ERYTHEMA 1 0.0000
289 HYPERTENSION 1 0.0000
290 DECREASED APPETITE 1 0.0000
291 BACK PAIN 1 0.0000
292 DIZZINESS 2 0.0000
293 WEIGHT DECREASED 1 0.0000
294 FALL 1 0.0000
295 ASTHENIA 1 0.0000
296 DEATH 2 0.0000
297 PAIN 1 0.0000
298 HEADACHE 1 0.0000
299 FATIGUE 1 0.0000